Legal Representation
Attorney
Joshua S. Jarvis, Esq.
USPTO Deadlines
Next Deadline
1588 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-28)
Due Date
November 28, 2029
Grace Period Ends
May 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
36 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 28, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 28, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Oct 26, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Oct 25, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Oct 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 2, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 2, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 23, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 23, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Jul 23, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Jun 30, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Jun 30, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
Jun 28, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jun 8, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jun 8, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
Jun 8, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
Jun 8, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jun 2, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 31, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
May 31, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
May 31, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 6, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 21, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 8, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 7, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 7, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 6, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
Aug 4, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 1, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 1, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 1, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development; scientific research and development, namely, inputting, collecting, defining, modeling, analyzing, and validating data related to gene signatures and biomarkers for the purposes of drug development; customizing computer software related to inputting, collecting, defining, modeling, analyzing, and validating data related to gene signatures and biomarkers for the purposes of drug development
First Use Anywhere:
20211100
First Use in Commerce:
20220100
Additional Information
Pseudo Mark
RESPONDER I D
Classification
International Classes
042